Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Imatinib & Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) (Ph+ CML), on December 20, 2002, the FDA granted accelerated approval for imatinib as first‑line treatment of newly diagnosed Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) (Ph+ CML) in chronic phase, based on the IRIS trial versus interferon‑alpha plus cytarabine (1, 2).
The EMA has approved imatinib for Chronic myeloid leukemia / Chronic myelogenous leukemia (CM…